Allogeneic hematopoietic stem cell transplantation outcome in oldest known surviving patients with Wiskott-Aldrich syndrome

Allogeneic hematopoietic stem cell transplantation outcome in oldest known surviving patients with Wiskott-Aldrich syndrome

Regardless of their age, adult patients with Wiskott-Aldrich syndrome should be considered for hematopoietic stem cell transplantation if clinically indicated.

Bibliographic Details
Main Authors:	Ariharan Anantharachagan, MBChB, MRCP, MsC,FRCPath, Sook Yin Loh, MBBCh, MRCP, Siobhan O. Burns, MB PhD, Arian Laurence, PhD, MRCP, FRCPath, Susan Tadros, MBBS, BSc, MRCP, FRCPath, Eleni Tholouli, MD, PhD, Yadanar Lwin, MBBS, MMed (Infn, Imm), FRACP, FRCPA, Nicolas Martinez-Calle, MD, PhD, P. Vaitla, MBBS, MRCP, FRCPath, Emma C. Morris, PhD, FMedSci
Format:	Article
Language:	English
Published:	Elsevier 2024-02-01
Series:	Journal of Allergy and Clinical Immunology: Global
Subjects:	Wiskott-Aldrich syndrome WAS hematopoietic stem cell transplantation HSCT adult
Online Access:	http://www.sciencedirect.com/science/article/pii/S2772829323001169

Internet

http://www.sciencedirect.com/science/article/pii/S2772829323001169